A Clinical Study of Arfolitixorin in Patients With mCRC
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Metastatic Colorectal Cancer (mCRC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Charité - Universitaetsmedizin Berlin, Berlin, Germany
Contact: Study coordinator (Sebastian Stintzing, Prof. Dr. MD) · sebastian.stintzing@charite.de · +49 30 450 513 002Universitaetsklinikum Essen AöR, Department of Medical Oncology, Essen, Germany
Contact: Study coordinator (Stefan Kasper-Virchow) · stefan.kasper-virchow@uk-essen.de · +492017233449Muenchen Klinik gGmbH, Klinik für Onkologie und Hämatologie, München, Germany
Study leads
Sebastian Stintzing, Prof. Dr. MD
Principal Investigator
Charité - Universitaetsmedizin Berlin, Berlin, 10117